Assessing Choice in the Employer Setting (ACES) Study (MA181)

MedImmune

Status

Completed

Conditions

Healthy

Treatments

Biological: Choice of TIV or FluMist with baseline advertisement

Biological: Control - Usual care offering TIV only with baseline advertisement

Other: Choice of TIV or FluMist with enhanced advertisement and incentives

Study type

Observational

Funder types

Other

Industry

Identifiers

NCT00808808

MI-MA-181

Details and patient eligibility

About

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

Full description

The primary objective is to determine, among adults in the 18-49 year old population and in the total population, the effects of offering a choice of FluMist or TIV with and without enhanced advertisement/added incentive on the overall influenza vaccination rates in the employer setting when compared to a control group.

Enrollment

4,411 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for employer sites:

Located in the United States
Has not previously offered FluMist in an employee vaccination program in the past or FluMist represented less than 5% of all vaccine received at past programs
Data are available that will allow for a reliable estimate of the employee (total and 18-49 year old populations) vaccination rate for the 2007-2008 influenza season